Washington Post |
FDA nominee to recuse himself from decisions on more than 20 health-care companies
Washington Post President Trump's nominee to lead the Food and Drug Administration plans to recuse himself for a year from agency decisions involving more than 20 companies that he has worked for, invested in or had some other kind of financial relationship with, ... FDA Nominee to Recuse Himself From Decisions on at Least 20 Companies FDA nominee Scott Gottlieb plans recusals from decisions on many drug firms Former FDA commissioner Mark McClellan comments on Trump's appointee to lead the agency |
from Health - Google News http://ift.tt/2o8l3og
EmoticonEmoticon